中證網訊(xun)（王(wang)珞(luo)）安科(ke)生物（300009）近(jin)日(ri)公(gong)(gong)告(gao)，基于對(dui)公(gong)(gong)司未來(lai)發展前景的信心(xin)以及對(dui)公(gong)(gong)司長期價值的高度認可，同時為(wei)維持資(zi)本(ben)市場穩定、增強(qiang)投資(zi)者信心(xin)，公(gong)(gong)司董事、副(fu)總裁(cai)周源(yuan)源(yuan)計(ji)劃(hua)自(zi)本(ben)公(gong)(gong)告(gao)披露之(zhi)日(ri)起(qi)6個(ge)月內通過集中競價交易方式(shi)累計(ji)增持公(gong)(gong)司股(gu)份數量不低于100萬股(gu)（含(han)）。

　　公(gong)(gong)告(gao)顯示，周(zhou)源(yuan)源(yuan)系實(shi)(shi)際(ji)控制人之(zhi)一宋(song)禮華配偶，本(ben)(ben)次(ci)增(zeng)(zeng)持(chi)(chi)計(ji)劃實(shi)(shi)施(shi)前(qian)，周(zhou)源(yuan)源(yuan)持(chi)(chi)有公(gong)(gong)司(si)股份(fen)(fen)(fen)118.7396萬股，占公(gong)(gong)司(si)總(zong)股本(ben)(ben)的(de)0.07%，除本(ben)(ben)次(ci)增(zeng)(zeng)持(chi)(chi)計(ji)劃外(wai)，周(zhou)源(yuan)源(yuan)在本(ben)(ben)公(gong)(gong)告(gao)披(pi)露(lu)之(zhi)日(ri)前(qian)12個月內未(wei)披(pi)露(lu)增(zeng)(zeng)持(chi)(chi)計(ji)劃；在本(ben)(ben)公(gong)(gong)告(gao)披(pi)露(lu)之(zhi)日(ri)前(qian)6個月，不(bu)(bu)存在減持(chi)(chi)公(gong)(gong)司(si)股份(fen)(fen)(fen)的(de)情形。本(ben)(ben)次(ci)增(zeng)(zeng)持(chi)(chi)將(jiang)采(cai)用自有資金(jin)，同時本(ben)(ben)次(ci)增(zeng)(zeng)持(chi)(chi)不(bu)(bu)設(she)定價(jia)(jia)格區間(jian)，將(jiang)根據市場整體(ti)走勢及對(dui)公(gong)(gong)司(si)股份(fen)(fen)(fen)價(jia)(jia)值(zhi)的(de)合理判斷，擇機實(shi)(shi)施(shi)增(zeng)(zeng)持(chi)(chi)計(ji)劃。此外(wai)，增(zeng)(zeng)持(chi)(chi)主體(ti)承諾，周(zhou)源(yuan)源(yuan)將(jiang)嚴格遵守(shou)有關法(fa)律(lv)法(fa)規(gui)的(de)規(gui)定，在本(ben)(ben)次(ci)增(zeng)(zeng)持(chi)(chi)計(ji)劃實(shi)(shi)施(shi)期間(jian)以及增(zeng)(zeng)持(chi)(chi)計(ji)劃完成后6個月內不(bu)(bu)減持(chi)(chi)其所(suo)持(chi)(chi)有的(de)公(gong)(gong)司(si)股份(fen)(fen)(fen)，不(bu)(bu)進行內幕交(jiao)(jiao)易、敏感期買賣公(gong)(gong)司(si)股份(fen)(fen)(fen)和短(duan)線(xian)交(jiao)(jiao)易。